Novel peptide therapeutics for treatment of infections
Open Access
- 1 August 2009
- journal article
- review article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 58 (8), 977-987
- https://doi.org/10.1099/jmm.0.011122-0
Abstract
As antibiotic resistance increases worldwide, there is an increasing pressure to develop novel classes of antimicrobial compounds to fight infectious disease. Peptide therapeutics represent a novel class of therapeutic agents. Some, such as cationic antimicrobial peptides and peptidoglycan recognition proteins, have been identified from studies of innate immune effector mechanisms, while others are completely novel compounds generated in biological systems. Currently, only selected cationic antimicrobial peptides have been licensed, and only for topical applications. However, research using new approaches to identify novel antimicrobial peptide therapeutics, and new approaches to delivery and improving stability, will result in an increased range of peptide therapeutics available in the clinic for broader applications.Keywords
This publication has 101 references indexed in Scilit:
- Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37Antimicrobial Agents and Chemotherapy, 2009
- Chronic Pharmacological and Safety Evaluation of Hematide™, a PEGylated Peptidic Erythropoiesis‐Stimulating Agent, in RodentsBasic & Clinical Pharmacology & Toxicology, 2009
- APD2: the updated antimicrobial peptide database and its application in peptide designNucleic Acids Research, 2008
- ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosaMicrobiology, 2008
- Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding AgentAntimicrobial Agents and Chemotherapy, 2008
- Discovery of antibacterial cyclic peptides that inhibit the ClpXP proteaseProtein Science, 2007
- Peptide Antimicrobial AgentsClinical Microbiology Reviews, 2006
- Crystal structure of human peptidoglycan recognition protein Iα bound to a muramyl pentapeptide from Gram‐positive bacteriaProtein Science, 2006
- Crystal Structure of Human Peptidoglycan Recognition Protein S (PGRP-S) at 1.70Å ResolutionJournal of Molecular Biology, 2005
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005